HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bioterror Regs Should Give Firms 24 Hours To Access Products, CRN Says

This article was originally published in The Tan Sheet

Executive Summary

FDA's proposed rule on food facility recordkeeping should focus more on the time needed to retrieve potentially contaminated foods and supplements than on the time necessary to access records that trace the products' whereabouts, according to the Council for Responsible Nutrition

You may also be interested in...



CFSAN Scrutinizing Bioterror Reg Comments As Center Gets Funding Boost

FDA's Center for Food Safety & Applied Nutrition may lengthen the timeframe to access records of dietary supplement and food manufacturers in bioterror emergencies that is currently provided in the agency's proposed rule on food facility recordkeeping

Administrative Detention, Class I Recall Conditions Need Clarification – CRN

FDA's administrative detention proposed rule does not adequately differentiate between a "credible threat" of bioterrorism and problems that would prompt a Class I recall, the Council for Responsible Nutrition states in July 8 comments to the agency

Recordkeeping Proposal Sets Different Measures For Transporters, Holders

Non-transporters of food products would have to keep records on both the immediately previous and subsequent holders and transporters of foods under FDA's proposed rule on the establishment and maintenance of records published in the May 9 Federal Register

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel